
HealthTech
Aayul
Aayul is building a precision-oncology platform using CAR-T technology to reprogramme patients’ immune cells to fight blood cancers and solid tumours. Through its AIIMS Delhi partnership and India-based manufacturing, it aims to make advanced therapies more effective, accessible and commercially scalable while developing proprietary IP.
T9L is co-building the business, shaping its IP, clinical and regulatory strategy, infrastructure, partnerships, funding and commercial model to take therapies from the laboratory to patients and global markets.
.webp&w=3840&q=75)


.webp&w=3840&q=75)